Physician profile
Michael P Ryan
NPI 1720396153
$3,416.25
in general payments reported to CMS, 2019-2025
36 companies · $537 in 2025
The $537 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $960 · 2022: $833 · 2023: $632 · 2024: $454 · 2025: $537.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,624.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,623.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $654.88 | 2021-2025 | |
| Tris Pharma INC | $405.67 | 2021-2025 | Dyanavel Xr, Onyda Xr, Quillichew Er |
| Merck Sharp & Dohme LLC | $324.02 | 2021-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Lilly USA, LLC | $234.54 | 2021-2025 | Mounjaro, Zepbound, Trulicity |
| Corium, LLC | $214.48 | 2022-2025 | Azstarys |
| Supernus Pharmaceuticals, INC. | $207.67 | 2021-2024 | Qelbree, Qelbree |
| Ironshore Pharmaceuticals INC. | $158.55 | 2022-2024 | Jornay Pm |
| Takeda Pharmaceuticals U.S.A., INC. | $121.56 | 2021-2023 | |
| Novo Nordisk INC | $118.62 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Sanofi Pasteur INC. | $96.47 | 2021-2025 | |
| Cranial Technologies, INC | $85.60 | 2021-2025 | Doc Band |
| Seqirus USA INC | $82.06 | 2021-2025 | Flucelvax |
| Adlon Therapeutics L.P. | $73.98 | 2021 | |
| Sobi, INC | $67.98 | 2021-2023 | |
| Glaxosmithkline, LLC. | $62.19 | 2022 |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Ryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.